Drug rollover trial offers ongoing hope for rare blood and transplant patients
NCT ID NCT04640025
First seen Jan 08, 2026 · Last updated May 22, 2026 · Updated 26 times
Summary
This study gives continued access to the drug itacitinib for people who were already taking it in a previous study and were doing well. It includes patients with myelofibrosis, chronic graft-versus-host disease, or bronchiolitis obliterans after a lung transplant. The goal is to keep providing the treatment as long as it helps and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anschutz Cancer Pavilion-University of Colorado
Aurora, Colorado, 80045, United States
-
Aou San Giovanni Di Dio E Ruggi
Salerno, 84131, Italy
-
Azienda Ospedaliera Bianchi-Melacrino-Morelli Ospedali Riuniti
Reggio Calabria, 89100, Italy
-
Azienda Policlinico Vittorio Emanuele
Catania, 95123, Italy
-
City of Hope National Medical Center
Duarte, California, 31010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Hadassah Hebrew University Medical Center Ein Karem Hadassah
Jerusalem, 91120, Israel
-
Hospital Universitario Ramon Y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen de Las Nieves
Granada, 18012, Spain
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Ordensklinikum Linz Gmbh Elisabethinen
Linz, 04020, Austria
-
Parkview Cancer Institute
Fort Wayne, Indiana, 46845, United States
-
Providence Health
Vancouver, British Columbia, V6Z 2A5, Canada
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Temple University Department of Thoracic Medicine and Surgery
Philadelphia, Pennsylvania, 19140, United States
-
Texas Oncology San Antonio
San Antonio, Texas, 78240, United States
-
Universitaire Ziekenhuis Leuven - Gasthuisberg
Leuven, 03000, Belgium
-
Universitatsklinikum Halle (Saale)
Halle, D06120, Germany
-
University Hospital Mannheim
Mannheim, 68167, Germany
-
University Hospital of West Attica - Attikon
Chaïdári, 12462, Greece
-
University Medical Centre Hamburg-Eppendorf Centre of Oncology
Hamburg, 20251, Germany
Conditions
Explore the condition pages connected to this study.